Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUGT1P4-STRA6LP is a readthrough locus formed by the fusion of an upstream SUGT1P4 pseudogene and a STRA6L pseudogene, located on human chromosome 9. The readthrough produces a set of transcripts predicted to be subject to nonsense-mediated decay and are therefore not believed to give rise to any functional protein[1][3][5][10][11]. This locus is classified as a pseudogene and is not implicated in any known biological function or disease. While pseudogenes in general can play roles in gene regulation through RNA-mediated mechanisms, there is no evidence that SUGT1P4-STRA6LP acts as a regulator or has pathological significance in humans[1][4][9]. Pseudogenes are typically considered “nonfunctional” DNA segments resembling functional genes but lacking the ability to encode full-length, functional proteins[4]. Occasionally, pseudogene-derived RNAs may regulate other genes, but SUGT1P4-STRA6LP has not been characterized as performing such a role[1][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SUGT1P4-STRA6-like pseudogene readthrough (SUGT1P4-STRA6LP).